logo

For the Inventor, By the Inventor

Wayland, MA, United States of America

John L Neumeyer

This inventor holds 20 USPTO granted patents and 1 EPO patent. Top assignees: The Mclean Hospital Corporation, Neuro Imaging Technologies, LLC, Northeastern University. Active years: 1977-2018.

IDiyas Innovation Intelligence. (2026). Inventor Profile: John L Neumeyer. Retrieved from https://idiyas.com/inventor/john-l-neumeyer

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 20

% Patents Active = 75.0


Average Co-Inventor Count = 2.3

ph-index = 7

Forward Citations = 124(Granted Patents)


Company Filing History:

goldMedal9 out of 125 
 
The Mclean Hospital Corporation
 patents
silverMedal3 out of 3 
 
Neuro Imaging Technologies, LLC
 patents
bronzeMedal3 out of 686 
 
Northeastern University
 patents
4. 2 out of 2 
 
Research Biochemicals Limited Partnership
 patents
5. 1 out of 18 
 
Amersham Plc
 patents
6. 1 out of 17 
 
Astra Pharmaceutical Products, Inc.
 patents
7. 1 out of 1,425 
 
The Brigham and Women's Hospital, Inc.
 patents
8. 1 out of 1,217 
 
The United States of America as Represented by the Department of Health
 patents
9. 1 out of 994 
 
University of Rochester
 patents
where one patent can have more than one assignee

Years Active: 1977-2018

Loading Chart...
Loading Chart...
20 patents (USPTO):Explore Patents
1. 10081600 - 2-alkoxy-11-hydroxyaporphine derivatives and uses thereof (2018-09-25),
2. 9517279 - 2-alkoxy-11-hydroxyaporphine derivatives and uses thereof (2016-12-13),
3. 8431591 - R(−)-2-methoxy-11-hydroxyaporphine and derivatives thereof (2013-04-30),
4. 8063060 - R(−)-11-hydroxyaporphine derivatives and uses thereof (2011-11-22),
5. 7648995 - R(—)-11-hydroxyaporphine derivatives and uses thereof (2010-01-19),
6. 7291628 - Treatment of cocaine abuse using N-substituted derivatives of morphinan (2007-11-06),
7. 7271173 - [object Object] (2007-09-18),
8. 6844438 - N-substituted derivatives of morphinan and uses thereof (2005-01-18),
9. 6537522 - Neuroprobes for mapping monoamine reuptake sites (2003-03-25),
10. 5750089 - Halogenated neuroprobe for mapping monoamine reuptake sites (1998-05-12),
11. 5700446 - Synthesis of ferrocenyl phenyltropane analogs and their (1997-12-23),
12. 5698179 - Iodinated neuroprobe for mapping monoamine reuptake sites (1997-12-16),
13. 5453426 - Sulfur-containing xanthine derivatives as adenosine antagonists (1995-09-26),
14. 5439666 - Iodinated neuroprobe for mapping monoamine reuptake sites (1995-08-08),
15. 5310912 - Iodinated neuroprobe for mapping monoamine reuptake sites (1994-05-10),

Title: John L. Neumeyer: Innovator in Aporphine Derivatives and Their Medical Applications

Introduction: John L. Neumeyer, based in Wayland, MA, is a distinguished inventor recognized for his significant contributions to the field of medicinal chemistry. With 20 patents to his name, Neumeyer has focused his innovative efforts on developing compounds that hold potential for treating a range of neurological and psychological disorders.

Latest Patents: Among his latest inventions are the patents for 2-alkoxy-11-hydroxyaporphine derivatives. These groundbreaking compounds selectively bind to D-receptors, making them valuable for both imaging D-receptors and treating diseases such as Parkinson's disease, sexual dysfunction, and depressive disorders. This work highlights Neumeyer's commitment to addressing critical health challenges through innovation.

Career Highlights: Neumeyer has had a notable career with significant affiliations, including roles at the McLean Hospital Corporation and Northeastern University. His work in these institutions has facilitated the research and development of his patented inventions, allowing him to contribute meaningful advancements in medical science.

Collaborations: Throughout his career, Neumeyer has collaborated with other prominent figures in the field, including Richard A. Milius and Robert B. Innis. These partnerships have enriched his research endeavors and led to the successful development of valuable medical compounds.

Conclusion: John L. Neumeyer's innovative spirit and dedication to advancing medicinal chemistry have established him as a valuable contributor to the scientific community. His work on 2-alkoxy-11-hydroxyaporphine derivatives reflects his commitment to improving healthcare through targeted interventions. As his research progresses, the potential impact of his inventions on treating various diseases continues to grow.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…